3QIN image
Deposition Date 2011-01-27
Release Date 2011-04-20
Last Version Date 2023-09-13
Entry Detail
PDB ID:
3QIN
Title:
Crystal Structure of HIV-1 RNase H p15 with engineered E. coli loop and pyrimidinol carboxylic acid inhibitor
Biological Source:
Method Details:
Experimental Method:
Resolution:
1.70 Å
R-Value Free:
0.25
R-Value Work:
0.22
R-Value Observed:
0.22
Space Group:
I 21 21 21
Macromolecular Entities
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Fusion protein of HIV-1 RNase H p15 with engineered E. coli loop
Gene (Uniprot):gag-pol, rnhA
Chain IDs:A
Chain Length:150
Number of Molecules:1
Biological Source:Human immunodeficiency virus type 1 group M subtype B, Escherichia coli (strain K12), Human immunodeficiency virus type 1 group M subtype B (isolate HXB2)
Primary Citation
Structural and Binding Analysis of Pyrimidinol Carboxylic Acid and N-Hydroxy Quinazolinedione HIV-1 RNase H Inhibitors.
Antimicrob.Agents Chemother. 55 2905 2915 (2011)
PMID: 21464257 DOI: 10.1128/AAC.01594-10

Abstact

HIV-1 RNase H breaks down the intermediate RNA-DNA hybrids during reverse transcription, requiring two divalent metal ions for activity. Pyrimidinol carboxylic acid and N-hydroxy quinazolinedione inhibitors were designed to coordinate the two metal ions in the active site of RNase H. High-resolution (1.4 Å to 2.1 Å) crystal structures were determined with the isolated RNase H domain and reverse transcriptase (RT), which permit accurate assessment of the metal and water environment at the active site. The geometry of the metal coordination suggests that the inhibitors mimic a substrate state prior to phosphodiester catalysis. Surface plasmon resonance studies confirm metal-dependent binding to RNase H and demonstrate that the inhibitors do not bind at the polymerase active site of RT. Additional evaluation of the RNase H site reveals an open protein surface with few additional interactions to optimize active-site inhibitors.

Legend

Protein

Chemical

Disease

Primary Citation of related structures